Archives

by in
Entry Author Date Location
Where Will the New Disease Treatments Come From a Decade From Now? 07/15/10 San Francisco
Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston 04/12/10 Boston
Ascent Changes to Anchor 03/30/10 Boston
Ischemix Faces Moment of Truth with Mid-Stage Heart Drug Trial 03/16/10 Boston
Sequel Pharmaceuticals’ CEO on How to Start a Biotech and Sell it For a Bundle, and Repeat 10/28/09 San Diego
Accumetrics Gunning To Be the Medical Diagnostics Standard for Managing Cardiovascular Disease 06/19/09 San Diego
Molecular Insight Names Peters CEO 05/13/09 Boston
Acusphere Cuts 40 Jobs 03/04/09 Boston
Isis Inches Closer Toward Profitability 02/25/09 San Diego
HeartWare Takes $282M Buyout 02/13/09 Boston
Imaging Agent for Early Detection of Heart Disease, From Molecular Insight, Reaches Goal 12/23/08 Boston
Epix Wins FDA Approval of Vasovist 12/22/08 Boston
FDA Panel Votes Down Acusphere Drug 12/10/08 Boston
Acusphere Stock Temporarily Halted During FDA Panel on Heart Imaging Drug 12/10/08 Boston
Isis Pharmaceuticals’ Second Drug Aims to Block Marker of Heart Disease, Inflammation 10/16/08 San Diego
Provasculon, a Biogen-backed Startup, Testing Regenerative Medicine on Hearts 10/09/08 Boston
Cortria Hires CEO Grau To Develop Heart Drugs That Won’t Make You Red in the Face 07/16/08 Boston
Rocky Mountain High: Atlas Venture Is Banking on microRNA for Miragen 05/22/08 Boston
Page 2 of 2 « previous page